Reasons to Retain STE Stock in Your Portfolio Now [Yahoo! Finance]
Globus Medical, Inc. Class A (GMED)
Last globus medical, inc. class a earnings: 2/20 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.globusmedical.com
Company Research
Source: Yahoo! Finance
How has STE's stock performed year-to-date compared to the industry and the S&P 500? Year to date, shares of STE have lost 2.1% against the industry's 7.6% growth and the S&P 500's 18.4% increase. Was this helpful? Yes No Are there other medical stocks that are considered better picks than STE? Yes, some better-ranked stocks in the broader medical space include Haemonetics (HAE), Penumbra (PEN), and Globus Medical (GMED), which have shown strong earnings growth and stock performance. Was this helpful? Yes No What is the current earnings estimate trend for STE's fiscal 2025 earnings? In the past 30 days, the Zacks Consensus Estimate for STE's fiscal 2025 earnings increased 0.9% to $9.10 per share. Was this helpful? Yes No What are the key challenges facing STE in the current market? STERIS faces foreign currency risks, as nearly 30% of the company's revenues and cost of revenues are generated outside the United States, making it vulnerable to foreign cu
Show less
Read more
Impact Snapshot
Event Time:
GMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMED alerts
High impacting Globus Medical, Inc. Class A news events
Weekly update
A roundup of the hottest topics
GMED
News
- Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Truist Financial Co. from $85.00 to $90.00. They now have a "hold" rating on the stock.MarketBeat
- Confocal Microscope Market is Projected to Reach $1.8 Billion with 3.3% CAGR by 2034 | Fact.MR Report [Yahoo! Finance]Yahoo! Finance
- Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Roth Mkm from $100.00 to $115.00. They now have a "buy" rating on the stock.MarketBeat
- Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at BTIG Research from $87.00 to $91.00. They now have a "buy" rating on the stock.MarketBeat
- Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Wells Fargo & Company from $88.00 to $95.00. They now have an "overweight" rating on the stock.MarketBeat
GMED
Earnings
- 11/5/24 - Beat
GMED
Sec Filings
- 12/4/24 - Form 4
- 12/2/24 - Form 144
- 11/25/24 - Form 4
- GMED's page on the SEC website